Journal History
| 2012 | The inaugural issue was released. Antibodies was published as a quarterly journal. |
| 2014 | Antibodies was indexed in Emerging Sources Citation Index (ESCI)—Web of Science (Clarivate Analytics), starting with Volume 1 (Issue 1). |
| 2019 | Antibodies was indexed in PubMed Central (PMC)—National Library of Medicine (NLM), starting with Volume 5 (Issue 1). |
| 2021 | Antibodies was indexed in Scopus (Elsevier), starting with Volume 1 (Issue 1). |
| 2022 |
Antibodies received its first CiteScore (2021) of 0.9. Antibodies established the following sections: |
| 2023 |
Antibodies received its first Impact Factor 4.7, ranked 2/16 in the category “Immunology” in ESCI. Antibodies received its second CiteScore (2022) of 9.6. |
| 2024 |
Antibodies received its 2023 Impact Factor (3.0), ranked 105/181 in the category “Immunology”. |
Editor-in-Chief
| 2011–2014 | Editor-in-Chief: Prof. Dr. Tomohiro Kurosaki |
| 2014–2022 | Editor-in-Chief: Prof. Dr. Dimiter S. Dimitrov |
| 2022–present | Editor-in-Chief: Prof. Dr. Arne Skerra |
Section Editor-in-Chief
| 2022–present | Section Editor-in-Chief: Prof. Dr. Linqi Zhang for the section on Humoral Immunity |
